Journal
CARCINOGENESIS
Volume 39, Issue 1, Pages 11-20Publisher
OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgx117
Keywords
-
Categories
Funding
- [R01CA160674]
- [T32HL007093]
- [R01CA181308]
Ask authors/readers for more resources
Cancer often arises in preneoplastic fields of histologically normal appearance. These fields have been extensively studied in ulcerative colitis, a cancer predisposing inflammatory bowel disease. Here, we review the field effect in ulcerative colitis and its utility to improve early cancer detection.Cumulative evidence indicates that a significant proportion of cancer evolution may occur before the development of histological abnormalities. While recent improvements in DNA sequencing technology have begun to reveal the presence of these early preneoplastic clones, the concept of 'premalignant field' was already introduced by Slaughter more than half a century ago. Also referred to as 'field effect', 'field defect' or 'field cancerization', these terms describe the phenomenon by which molecular alterations develop in normal-appearing tissue and expand to form premalignant patches with the potential to progress to dysplasia and cancer. Field effects have been well-characterized in ulcerative colitis, an inflammatory bowel disease that increases the risk of colorectal cancer. The study of the molecular alterations that define these fields is informative of mechanisms of tumor initiation and progression and has provided potential targets for early cancer detection. Herein, we summarize the current knowledge about the molecular alterations that comprise the field effect in ulcerative colitis and the clinical utility of these fields for cancer screening and prevention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available